Your browser doesn't support javascript.
loading
Genetic Variants Associated With Unexplained Sudden Cardiac Death in Adult White and African American Individuals.
Guo, Liang; Torii, Sho; Fernandez, Raquel; Braumann, Ryan E; Fuller, Daniela T; Paek, Ka-Hyun; Gadhoke, Neel V; Maloney, Kristin A; Harris, Kathryn; Mayhew, Christina M; Zarpak, Roya; Stevens, Laura M; Gaynor, Brady J; Jinnouchi, Hiroyuki; Sakamoto, Atsushi; Sato, Yu; Mori, Hiroyoshi; Kutyna, Matthew D; Lee, Parker J; Weinstein, Leah M; Collado-Rivera, Carlos J; Ali, Bakr B; Atmakuri, Dheeraj R; Dhingra, Roma; Finn, Emma L B; Bell, Mack W; Lynch, Megan; Cornelissen, Anne; Kuntz, Salome H; Park, Joo-Hyung; Kutys, Robert; Park, Ji-Eun; Wang, Libin; Hong, Susie N; Gupta, Anuj; Hall, Jennifer L; Kolodgie, Frank D; Romero, Maria E; Jeng, Linda J B; Mitchell, Braxton D; Surve, Dipti; Fowler, David R; Hong, Charles C; Virmani, Renu; Finn, Aloke V.
Afiliação
  • Guo L; CVPath Institute, Gaithersburg, Maryland.
  • Torii S; currently with Bioscience Cardiovascular Research and Early Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, Maryland.
  • Fernandez R; CVPath Institute, Gaithersburg, Maryland.
  • Braumann RE; currently with Department of Cardiology, Tokai University School of Medicine, Kanagawa, Japan.
  • Fuller DT; CVPath Institute, Gaithersburg, Maryland.
  • Paek KH; CVPath Institute, Gaithersburg, Maryland.
  • Gadhoke NV; CVPath Institute, Gaithersburg, Maryland.
  • Maloney KA; CVPath Institute, Gaithersburg, Maryland.
  • Harris K; CVPath Institute, Gaithersburg, Maryland.
  • Mayhew CM; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Zarpak R; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Stevens LM; CVPath Institute, Gaithersburg, Maryland.
  • Gaynor BJ; CVPath Institute, Gaithersburg, Maryland.
  • Jinnouchi H; Institute for Precision Cardiovascular Medicine, American Heart Association, Dallas, Texas.
  • Sakamoto A; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Sato Y; CVPath Institute, Gaithersburg, Maryland.
  • Mori H; CVPath Institute, Gaithersburg, Maryland.
  • Kutyna MD; CVPath Institute, Gaithersburg, Maryland.
  • Lee PJ; CVPath Institute, Gaithersburg, Maryland.
  • Weinstein LM; currently with Department of Internal Medicine, Division of Cardiology, Showa University Fujigaoka Hospital, Kanagawa, Japan.
  • Collado-Rivera CJ; CVPath Institute, Gaithersburg, Maryland.
  • Ali BB; CVPath Institute, Gaithersburg, Maryland.
  • Atmakuri DR; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Dhingra R; CVPath Institute, Gaithersburg, Maryland.
  • Finn ELB; CVPath Institute, Gaithersburg, Maryland.
  • Bell MW; CVPath Institute, Gaithersburg, Maryland.
  • Lynch M; CVPath Institute, Gaithersburg, Maryland.
  • Cornelissen A; CVPath Institute, Gaithersburg, Maryland.
  • Kuntz SH; CVPath Institute, Gaithersburg, Maryland.
  • Park JH; CVPath Institute, Gaithersburg, Maryland.
  • Kutys R; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Park JE; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Wang L; CVPath Institute, Gaithersburg, Maryland.
  • Hong SN; CVPath Institute, Gaithersburg, Maryland.
  • Gupta A; CVPath Institute, Gaithersburg, Maryland.
  • Hall JL; CVPath Institute, Gaithersburg, Maryland.
  • Kolodgie FD; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Romero ME; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Jeng LJB; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Mitchell BD; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Surve D; Institute for Precision Cardiovascular Medicine, American Heart Association, Dallas, Texas.
  • Fowler DR; CVPath Institute, Gaithersburg, Maryland.
  • Hong CC; CVPath Institute, Gaithersburg, Maryland.
  • Virmani R; US Food and Drug Administration, Silver Spring, Maryland.
  • Finn AV; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
JAMA Cardiol ; 6(9): 1013-1022, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34076677
ABSTRACT
Importance Unexplained sudden cardiac death (SCD) describes SCD with no cause identified. Genetic testing helps to diagnose inherited cardiac diseases in unexplained SCD; however, the associations between pathogenic or likely pathogenic (P/LP) variants of inherited cardiomyopathies (CMs) and arrhythmia syndromes and the risk of unexplained SCD in both White and African American adults living the United States has never been systematically examined.

Objective:

To investigate cases of unexplained SCD to determine the frequency of P/LP genetic variants of inherited CMs and arrhythmia syndromes. Design, Setting, and

Participants:

This genetic association study included 683 African American and White adults who died of unexplained SCD and were included in an autopsy registry. Overall, 413 individuals had DNA of acceptable quality for genetic sequencing. Data were collected from January 1995 to December 2015. A total of 30 CM genes and 38 arrhythmia genes were sequenced, and variants in these genes, curated as P/LP, were examined to study their frequency. Data analysis was performed from June 2018 to March 2021. Main Outcomes and

Measures:

The frequency of P/LP variants for CM or arrhythmia in individuals with unexplained SCD.

Results:

The median (interquartile range) age at death of the 413 included individuals was 41 (29-48) years, 259 (62.7%) were men, and 208 (50.4%) were African American adults. A total of 76 patients (18.4%) with unexplained SCD carried variants considered P/LP for CM and arrhythmia genes. In total, 52 patients (12.6%) had 49 P/LP variants for CM, 22 (5.3%) carried 23 P/LP variants for arrhythmia, and 2 (0.5%) had P/LP variants for both CM and arrhythmia. Overall, 41 P/LP variants for hypertrophic CM were found in 45 patients (10.9%), 9 P/LP variants for dilated CM were found in 11 patients (2.7%), and 10 P/LP variants for long QT syndrome were found in 11 patients (2.7%). No significant difference was found in clinical and heart characteristics between individuals with or without P/LP variants. African American and White patients were equally likely to harbor P/LP variants. Conclusions and Relevance In this large genetic association study of community cases of unexplained SCD, nearly 20% of patients carried P/LP variants, suggesting that genetics may contribute to a significant number of cases of unexplained SCD. Our findings regarding both the association of unexplained SCD with CM genes and race-specific genetic variants suggest new avenues of study for this poorly understood entity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Negro ou Afro-Americano / Sistema de Registros / Morte Súbita Cardíaca / População Branca / Estudos de Associação Genética / Cardiopatias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Negro ou Afro-Americano / Sistema de Registros / Morte Súbita Cardíaca / População Branca / Estudos de Associação Genética / Cardiopatias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article